ArticleFrontiers in oncology2020

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.

Yu Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.